Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.32B |
| 2 |
SCHR
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$1.22B |
| 3 |
Chevron
CVX
|
+$477M |
| 4 |
Pfizer
PFE
|
+$375M |
| 5 |
Amazon
AMZN
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$9.58B |
| 2 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.28B |
| 3 |
Schwab International Equity ETF
SCHF
|
+$4.53B |
| 4 |
Schwab U.S Small- Cap ETF
SCHA
|
+$4.13B |
| 5 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$2.63B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.59% |
| 2 | Financials | 12.1% |
| 3 | Healthcare | 10.58% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Apogee Therapeutics
APGE
$10.1B
| $16.5M | ﹤0.01% |
280,428
+41,686
| +17% | +$2M |
|
1802
Scorpio Tankers
STNG
$3.89B
| $16.5M | ﹤0.01% |
230,799
-29,822
| -11% | -$2.18M |
|
1803
Wabash National
WNC
$508M
| $16.4M | ﹤0.01% |
856,438
+46,451
| +6% | +$934K |
|
1804
Ligand Pharmaceuticals
LGND
$5.85B
| $16.4M | ﹤0.01% |
163,924
+8,584
| +6% | +$864K |
|
1805
Remitly
RELY
$5.05B
| $16.3M | ﹤0.01% |
1,220,966
+12,875
| +1% | +$175K |
|
1806
Kelly Services Class A
KELYA
$520M
| $16.3M | ﹤0.01% |
762,543
-225,234
| -23% | -$4.77M |
|
1807
Veeco
VECO
$3.28B
| $16.3M | ﹤0.01% |
491,516
-62
| -0% | -$2.32K |
|
1808
Avis
CAR
$4.91B
| $16.3M | ﹤0.01% |
185,801
+17,666
| +11% | +$1.59M |
|
1809
Dorian LPG
LPG
$1.97B
| $16.2M | ﹤0.01% |
471,768
+34,344
| +8% | +$1.3M |
|
1810
Perimeter Solutions
PRM
$4.99B
| $16.2M | ﹤0.01% |
1,205,662
-6,438
| -0.5% | -$66.7K |
|
1811
Teva Pharmaceuticals
TEVA
$40.1B
| $16.2M | ﹤0.01% |
899,175
+177,836
| +25% | +$3.11M |
|
1812
Scholastic
SCHL
$794M
| $16.1M | ﹤0.01% |
502,179
+41,864
| +9% | +$1.34M |
|
1813
Cohu
COHU
$2.5B
| $16M | ﹤0.01% |
624,274
+59,806
| +11% | +$1.68M |
|
1814
Vera Therapeutics
VERA
$2.31B
| $16M | ﹤0.01% |
361,805
+10,717
| +3% | +$407K |
|
1815
BioNTech
BNTX
$23.3B
| $15.9M | ﹤0.01% |
134,036
+74,119
| +124% | +$6.81M |
|
1816
Dole
DOLE
$1.36B
| $15.9M | ﹤0.01% |
975,286
-153,142
| -14% | -$2.29M |
|
1817
Pediatrix Medical
MD
$2.16B
| $15.8M | ﹤0.01% |
1,367,345
-247,868
| -15% | -$2.34M |
|
|
DCH
1818
Dauch Corp
DCH
$1.42B
| $15.8M | ﹤0.01% |
2,562,553
+65,535
| +3% | +$427K |
|
1819
STAAR Surgical
STAA
$1.21B
| $15.8M | ﹤0.01% |
426,122
-4,521
| -1% | -$169K |
|
1820
Camping World
CWH
$694M
| $15.8M | ﹤0.01% |
652,269
+65,798
| +11% | +$1.42M |
|
1821
Gulfport Energy Corp
GPOR
$2.8B
| $15.8M | ﹤0.01% |
104,256
+18,371
| +21% | +$2.7M |
|
1822
Immunovant
IMVT
$8.08B
| $15.7M | ﹤0.01% |
552,430
+91,259
| +20% | +$2.69M |
|
1823
Dave & Buster's
PLAY
$403M
| $15.7M | ﹤0.01% |
462,191
+15,015
| +3% | +$512K |
|
1824
Comstock Resources
CRK
$3.94B
| $15.7M | ﹤0.01% |
1,413,820
+57,376
| +4% | +$588K |
|
1825
CareDx
CDNA
$2.44B
| $15.6M | ﹤0.01% |
499,480
+13,547
| +3% | +$337K |
|
Similar funds
Charles Schwab's Q3 2024 Portfolio in Review
As of Q3 2024, Charles Schwab held 3,658 positions worth $524B, down 0.18% from $525B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab withdrew a net $33.1B in Q3 2024, closing 156 positions and reducing 1,005 holdings. Its most notable exit was Schwab US Large- Cap ETF, an estimated $9.58B position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Charles Schwab opened a new position in Shopify worth $194M.
- Charles Schwab's largest Q3 2024 buy was Shopify: 2,416,436 shares worth $194M.
- Charles Schwab added most to Apple in Q3 2024, an estimated $1.32B increase.
- Charles Schwab's biggest Q3 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $958M.
- Charles Schwab fully exited Schwab US Large- Cap ETF in Q3 2024, selling an estimated $9.58B.
- Charles Schwab's ten largest holdings make up 21% of its $524B portfolio in Q3 2024.
- Charles Schwab opened 39 new positions and closed 156 in Q3 2024.
- Charles Schwab's portfolio value fell 0.18% quarter-over-quarter to $524B.
Based on Charles Schwab's 13F filing for Q3 2024, filed 12 Nov 2024.